Discontinued — last reported Q2 '23
Womens Health — Sales to customers
Johnson & Johnson Womens Health — Sales to customers increased by 9.7% to $238.00M in Q2 2023 compared to the prior quarter. Year-over-year, this metric grew by 3.5%, from $230.00M to $238.00M. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates growing market share or higher demand for the company's women's health portfolio, while a decrease may signal competitive pressure or product lifecycle maturity.
Detailed definition
This metric represents the total revenue generated from the sale of products specifically designed for women's health ap...
Peer comparison
Comparable to specialized medical device or pharmaceutical segment revenues focused on reproductive health, oncology, or gynecological care at peer healthcare companies.
jnj_segment_women_s_health_sales_to_customersHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $230.00M | $232.00M | $233.00M | $228.00M | $230.00M | $225.00M | $221.00M | $217.00M | $238.00M |
| QoQ Change | — | +0.9% | +0.4% | -2.1% | +0.9% | -2.2% | -1.8% | -1.8% | +9.7% |
| YoY Change | — | — | — | — | +0.0% | -3.0% | -5.2% | -4.8% | +3.5% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's womens health — sales to customers?
- Johnson & Johnson (JNJ) reported womens health — sales to customers of $238.00M in Q2 2023.
- How has Johnson & Johnson's womens health — sales to customers changed year-over-year?
- Johnson & Johnson's womens health — sales to customers increased by 3.5% year-over-year, from $230.00M to $238.00M.
- What does womens health — sales to customers mean?
- The total revenue earned from selling products focused on women's health.